These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 28076379)

  • 21. CLEC3B is downregulated and inhibits proliferation in clear cell renal cell carcinoma.
    Liu J; Liu Z; Liu Q; Li L; Fan X; Wen T; An G
    Oncol Rep; 2018 Oct; 40(4):2023-2035. PubMed ID: 30066941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of the dopamine transporter SLC6A3 as a biomarker for patients with renal cell carcinoma.
    Schrödter S; Braun M; Syring I; Klümper N; Deng M; Schmidt D; Perner S; Müller SC; Ellinger J
    Mol Cancer; 2016 Feb; 15():10. PubMed ID: 26831905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
    Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X
    Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PRMT1 is a novel molecular therapeutic target for clear cell renal cell carcinoma.
    Wang J; Wang C; Xu P; Li X; Lu Y; Jin D; Yin X; Jiang H; Huang J; Xiong H; Ye F; Jin J; Chen Y; Xie Y; Chen Z; Ding H; Zhang H; Liu R; Jiang H; Chen K; Yao Z; Luo C; Huang Y; Zhang Y; Zhang J
    Theranostics; 2021; 11(11):5387-5403. PubMed ID: 33859753
    [No Abstract]   [Full Text] [Related]  

  • 25. hZIP1 that is down-regulated in clear cell renal cell carcinoma is negatively associated with the malignant potential of the tumor.
    Dong X; Kong C; Zhang Z; Liu X; Zhan B; Chen Z; Shi D
    Urol Oncol; 2014 Aug; 32(6):885-92. PubMed ID: 24878177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395.
    Sun G; Zhou H; Chen K; Zeng J; Zhang Y; Yan L; Yao W; Hu J; Wang T; Xing J; Xiao K; Wu L; Ye Z; Xu H
    J Exp Clin Cancer Res; 2020 Jun; 39(1):116. PubMed ID: 32560659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of BHLHE41, correlated with DNA hypomethylation in 3'UTR region, promotes the growth of human clear cell renal cell carcinoma.
    Shen Z; Zhu L; Zhang C; Cui X; Lu J
    Oncol Rep; 2019 Apr; 41(4):2137-2147. PubMed ID: 30816499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-19a correlates with poor prognosis of clear cell renal cell carcinoma patients via promoting cell proliferation and suppressing PTEN/SMAD4 expression.
    Ma Q; Peng Z; Wang L; Li Y; Wang K; Zheng J; Liang Z; Liu T
    Int J Oncol; 2016 Dec; 49(6):2589-2599. PubMed ID: 27779660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma.
    Wu XR; Sha JJ; Liu DM; Chen YH; Yang GL; Zhang J; Chen YY; Bo JJ; Huang YR
    Eur J Surg Oncol; 2013 Jan; 39(1):100-6. PubMed ID: 23102595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nucleobindin 2 expression is an independent prognostic factor for clear cell renal cell carcinoma.
    Qi C; Ma H; Zhang HT; Gao JD; Xu Y
    Histopathology; 2015 Apr; 66(5):650-7. PubMed ID: 25322808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SOX6 represses tumor growth of clear cell renal cell carcinoma by HMG domain-dependent regulation of Wnt/β-catenin signaling.
    Chen L; Xie Y; Ma X; Zhang Y; Li X; Zhang F; Gao Y; Fan Y; Gu L; Wang L; Zhang X; Fu B
    Mol Carcinog; 2020 Oct; 59(10):1159-1173. PubMed ID: 32794610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Far upstream element-binding protein 1(FUBP1) expression differs between human colorectal cancer and non-cancerous tissue.
    Jia MY; Wang YJ
    Neoplasma; 2014; 61(5):533-40. PubMed ID: 25030436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression.
    Chen X; Wang X; Ruan A; Han W; Zhao Y; Lu X; Xiao P; Shi H; Wang R; Chen L; Chen S; Du Q; Yang H; Zhang X
    Clin Cancer Res; 2014 May; 20(10):2617-30. PubMed ID: 24647573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells.
    Tang SW; Chang WH; Su YC; Chen YC; Lai YH; Wu PT; Hsu CI; Lin WC; Lai MK; Lin JY
    Cancer Lett; 2009 Jan; 273(1):35-43. PubMed ID: 18809243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LCAT3, a novel m6A-regulated long non-coding RNA, plays an oncogenic role in lung cancer via binding with FUBP1 to activate c-MYC.
    Qian X; Yang J; Qiu Q; Li X; Jiang C; Li J; Dong L; Ying K; Lu B; Chen E; Liu P; Lu Y
    J Hematol Oncol; 2021 Jul; 14(1):112. PubMed ID: 34274028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor suppressive microRNA‑429 regulates cellular function by targeting VEGF in clear cell renal cell carcinoma.
    Chen D; Li Y; Li Y; Jin L; Su Z; Yu Z; Yang S; Mao X; Lai Y
    Mol Med Rep; 2016 Feb; 13(2):1361-6. PubMed ID: 26647818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NOTCH1 functions as an oncogene by regulating the PTEN/PI3K/AKT pathway in clear cell renal cell carcinoma.
    Liu S; Ma X; Ai Q; Huang Q; Shi T; Zhu M; Wang B; Zhang X
    Urol Oncol; 2013 Aug; 31(6):938-48. PubMed ID: 21993533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-21 stimulates epithelial-to-mesenchymal transition and tumorigenesis in clear cell renal cells.
    Cao J; Liu J; Xu R; Zhu X; Liu L; Zhao X
    Mol Med Rep; 2016 Jan; 13(1):75-82. PubMed ID: 26572589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. KCNJ1 inhibits tumor proliferation and metastasis and is a prognostic factor in clear cell renal cell carcinoma.
    Guo Z; Liu J; Zhang L; Su B; Xing Y; He Q; Ci W; Li X; Zhou L
    Tumour Biol; 2015 Feb; 36(2):1251-9. PubMed ID: 25344677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Far upstream element -binding protein 1 (FUBP1) participates in the malignant process and glycolysis of colon cancer cells by combining with c-Myc.
    Wang S; Wang Y; Li S; Nian S; Xu W; Liang F
    Bioengineered; 2022 May; 13(5):12115-12126. PubMed ID: 35546072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.